FizzyBits™ Micro-Bubble Tablets Make Their European Debut with a New Approach to Supplementation

2026-09-16

【SIRIO News】

Author: SIRIO

Click:0

SIRIO has officially launched FizzyBits™ in Europe, its new micro-bubble tablet range comprising ten ready-to-go formulations. Designed for brands and consumers worldwide, FizzyBits™ brings greater convenience and enjoyment to everyday nutritional supplementation.


Format Innovation Redefines Supplementation


 

image.png


As large capsules and tablets become a barrier to regular supplementation, delivery format is playing an increasingly important role in consumer adherence. Innova Insights reports that 22% of consumers are taking more supplements simply because more appealing formats are now available1. This underscores the growing importance of format as part of a product's value proposition and its influence on consumer purchasing decisions.

 

Distinct from both traditional effervescent tablets and carbonated drinks, FizzyBits™ micro-bubble tablets open up a new category of fast-dissolving nutrient delivery. With rapid nutrient release and an improved taste experience, FizzyBits™ makes everyday supplementation simpler and more enjoyable.

 

Three Key Features Create New Supplementation Moments


Built around three key features, FizzyBits™ micro-bubble tablets bring simple, convenient and enjoyable supplementation into everyday life, from the morning commute and workout breaks to busy days at the office.

 

1. Water-Free Convenience, Rapid Release

Dissolves quickly on the tongue to release nutrients in moments

Turns supplementation into an effortless part of your daily routine

 

2. Natural Flavors, Clean Formulations

Eight natural flavors with a fruit base turn every bite into an enjoyable experience

Sugar-free and vegetarian-friendly options cater to a wider range of preferences

 

3. Clinical Evidence, Everyday Support

A versatile range of formulations supports everyday health, energy and vitality

Targeted metabolic health solutions are backed by clinical research for added scientific rigor

 

One Platform Addresses Diverse Health Needs

FizzyBits™ makes its European debut not simply as a range of ten products², but as a fully developed solution platform. Its standardized formulation portfolio enables brands to quickly expand into key health categories, including joint health, energy and vitality, and sports recovery.

 

Joint Health FizzyBits™ Flex

Combines active undenatured type II collagen with vitamins C and D, designed for middle-aged and older adults


image.png


Iron Nutrition FizzyBits™ Pulse

Pairs iron with vitamins C and B6 and folic acid to support absorption, while its lemon flavor helps mask the metallic taste


image.png


Energy & Vitality FizzyBits™ Energy

Powered by a full spectrum of B vitamins to support energy metabolism


image.png


Immune Support FizzyBits™ C/D/MV

Features single-vitamin C and D options and a multivitamin formula to meet everyday nutritional needs for the whole family


image.png


Sports Recovery FizzyBits™ Recovery

Combines vitamin C with electrolytes such as magnesium and sodium to support post-workout recovery


image.png


Metabolic Health Aeion™ BodyBalance

Formulated with clinically validated postbiotic BPL1® to deliver metabolic support in a convenient two-tablet daily serving³


 

image.png


Global Capabilities Unlock New Market Growth

More than a standalone product launch, FizzyBits™ reflects the strength of SIRIO's global innovation ecosystem and its pipeline of new solutions.

 

As a well-established global nutraceutical solution provider, SIRIO operates seven production bases and five R&D centers worldwide, launches more than 500 products each year, and maintains a portfolio of 6,000 established formulations.

 

Backed by global capabilities spanning R&D, manufacturing and commercialization, SIRIO turns its end-to-end innovation expertise into market-ready "Ready to Go" solutions, enabling brands to shorten time to market and scale high-quality innovations globally.

 

1. Data sources: Innova Trends Survey 2026; Innova Category Survey 2025.

2. The products in this range are intended for international markets.

3. Pedret, A., Valls, R. M., Calderón-Pérez, L., Llauradó, E., Companys, J., Pla-Pagà, L., ... & Solà, R. (2019). Effects of daily consumption of the probiotic Bifidobacterium animalis subsp. lactis CECT 8145 on anthropometric adiposity biomarkers in abdominally obese subjects: a randomized controlled trial. International journal of obesity, 43(9), 1863-1868.


Transform the Health of the World

Partnering worldwide to explore new frontiers in the nutraceutical industry

Contact us
X

*Required fields
×